Registration gives the benefit of receiving regular site update emails.
ADHD Institute Register

Daily reports from the 6th World Congress on ADHD – from child to adult disorder (Vancouver, Canada, 20–23 April 2017) and EUNETHYDIS 4th International Conference on ADHD: ADHD – from basic neuroscience to optimised clinical care (Berlin, Germany, 17–19 October 2016)

These conferences covered key issues related to child, adolescent and adult ADHD, clinical implications of scientific evidence, new technologies for studying ADHD and optimal management. These reports give a daily overview of the presentations covered and their relevance to clinicians involved in the diagnosis and treatment of ADHD across the lifespan.


Day 1: From child to adult disorder

WCADHD 6th World Congress on ADHD 2017

Day 1 of the 6th World Congress on ADHD, Vancouver, Canada brought the audience exciting hot topic symposia, research consortia sessions and industry sponsored symposia on topics including sex differences in ADHD, the role of noradrenaline in the pathophysiology and treatment of ADHD, the next generation of longitudinal studies and predictors of outcome in ADHD.

Read more >



Day 2: From child to adult disorder

WCADHD 6th World Congress on ADHD 2017

Day 2 of the 6th World Congress on ADHD, Vancouver, Canada brought the audience thought-provoking plenary sessions on future directions in ADHD, a passionate debate on the pros and cons of long-term pharmacological therapy and industry sponsored symposia. The afternoon provided engaging educational seminars, hot topic symposia and ‘meet the experts’ sessions on topics including comorbid ADHD and anxiety, the genetics of comorbid ADHD and mood disorders, and the assessment and treatment of ADHD during the transition from adolescence into adulthood.

Read more >



Day 3: From child to adult disorder

WCADHD 6th World Congress on ADHD 2017

Day 3 of the 6th World Congress on ADHD, Vancouver, Canada, delivered an innovative plenary session on advances in neurobiology of ADHD, a fascinating patient case study demonstrating the complexity of ADHD with comorbid psychiatric conditions and an industry sponsored symposium; all of which were received by busy auditoriums. The afternoon provided a number of hot topic symposia and educational seminars on topics such as the impact of adult ADHD on the course of delinquent behaviour, advances in the treatment of adult ADHD, and the diagnostic process and treatment planning for children.

Read more >



Day 4: From child to adult disorder

WCADHD 6th World Congress on ADHD 2017

The final day of the 6th World Congress on ADHD, Vancouver, Canada, ended with stimulating plenary presentations on new advances in ADHD diagnosis and treatment.

Read more >



Day 1: ADHD – from basic neuroscience to optimised clinical care

EUNETHYDIS 4th International Conference on ADHD 2016

Day 1 of the 4th EUNETHYDIS International Conference on ADHD, Berlin, Germany, brought the audience exciting plenary lectures and symposia on topics such as neuroimaging, adult ADHD and long-term effects of stimulant treatment. There was also lively debate on whether medication should always be first-line treatment for ADHD and the day concluded with an interview between Professor Coghill, Professor Sir Sergeant and Professor Taylor.

Read more >



Day 2: ADHD – from basic neuroscience to optimised clinical care

EUNETHYDIS 4th International Conference on ADHD 2016

Day 2 of the 4th EUNETHYDIS International Conference on ADHD, Berlin, Germany, brought the audience fascinating plenary lectures and symposia on topics such as emerging technologies in the diagnosis and assessment of ADHD, the clinical implementation of scientific evidence and the ethics surrounding an increasing number of healthy adults choosing to use pharmacological therapies licensed in ADHD for the “smart drug effect”. The day ended with a lively debate on whether adult ADHD is a child-onset neurodevelopmental disorder.

Read more >



Day 3: ADHD – from basic neuroscience to optimised clinical care

EUNETHYDIS 4th International Conference on ADHD 2016

The final day of the 4th EUNETHYDIS Conference on ADHD, Berlin, Germany, brought the audience exciting symposia and plenary lectures on topics such as motivation and emotion in ADHD, controversies and challenges in ADHD research, multimodal treatment, and the 16-year follow-up results from the Multimodal Treatment of Attention-Deficit Hyperactivity Disorder (MTA) study. During the prize-winners session, several prestigious prizes were awarded, including the ECAP Paper of the Year 2015 award and the Kramer-Pollnow Young Investigators 2016 award. The conference concluded with an exciting debate on the motion of whether Research Domain Criteria will prove a major progression for scientific research and clinical practice in ADHD.

Read more >





Filter content by:

ADHD Institue logo

You’re now being transferred to

and are leaving the ADHD Institute site

Shire has no influence or control over the content of this third party website.

Continue Cancel